At Labassure, we recognize the importance of proactive care during pregnancy—especially when it comes to high-risk conditions like pre-eclampsia. This potentially life-threatening hypertensive disorder can lead to serious complications for both mother and baby if not identified and managed in time. Our Pre-eclampsia Risk Assessment combines advanced biomarker testing to support early detection and informed clinical decision-making.
By measuring angiogenic and anti-angiogenic markers, this assessment helps predict the onset and progression of pre-eclampsia, particularly in women showing early signs such as elevated blood pressure or abnormal ultrasound findings.
Labassure’s Pre-eclampsia Risk Assessment offers clinicians a powerful tool for early intervention—helping ensure safer pregnancies and healthier outcomes for both mother and baby.
TAT - 5 days
Sample: 4ml Blood in Serum vial
TAT - 6 days
Sample: 4ml Blood in Serum vial